iCeutica, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire iCeutica, Inc.
Quantité totale PI 16
Rang # Quantité totale PI 97 631
Note d'activité PI 0,9/5.0    2
Rang # Activité PI 483 549
Parent Iroko Pharmaceuticals LLC
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

2 3
0 6
3 2
0
 
Dernier brevet 2025 - Formulation of metaxalone
Premier brevet 2013 - Method for improving the dissolu...
Dernière marque 2022 - SOLUMATRIX
Première marque 2013 - ICEUTICA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Formulation of metaxalone. Dosage forms of metaxalone containing submicron particles of metaxalo...
2022 P/S pharmaceutical preparations for the treatment of migraines, pain, inflammation, infection, respir...
2017 P/S Pharmaceutical drug development services; and laboratory research services relating to chemical c...
2016 P/S Pharmaceutical preparations for the treatment of migraines, pain, inflammation, namely, anti-infl...
P/S Pharmaceutical preparations for the treatment of migraines, pain, inflammation, infection, respi...
P/S pharmaceutical drug development services
Invention Novel formulation of naproxen. The present invention relates to methods for producing particles ...
P/S Nutraceuticals for use as a dietary supplement for general health and wellbeing and for promoting...
2015 Invention Abiraterone acetate formulation and methods of use. Pharmaceutical compositions, including unit d...
2014 Invention Formulation of metaxalone. Dosage forms of metaxalone containing submicron particles of metaxalon...
Invention Abiraterone acetate formulation. Pharmaceutical compositions, including unit dosage forms, compri...
2013 Invention Method for improving the dissolution profile of a biologically active material. A method for imp...
P/S Pharmaceutical preparations for the treatment of pain, cancer, respiratory diseases and condition...